These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19517103)

  • 1. Genetic basis of renal cellular dysfunction and the formation of kidney stones.
    Khan SR; Canales BK
    Urol Res; 2009 Aug; 37(4):169-80. PubMed ID: 19517103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation.
    Mo L; Huang HY; Zhu XH; Shapiro E; Hasty DL; Wu XR
    Kidney Int; 2004 Sep; 66(3):1159-66. PubMed ID: 15327412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Tamm-Horsfall protein and uromodulin in calcium oxalate crystallization.
    Carvalho M; Mulinari RA; Nakagawa Y
    Braz J Med Biol Res; 2002 Oct; 35(10):1165-72. PubMed ID: 12424489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Sodium-Induced Oxidative Stress and Poor Anticrystallization Defense Aggravate Calcium Oxalate Crystal Formation in Rat Hyperoxaluric Kidneys.
    Huang HS; Ma MC
    PLoS One; 2015; 10(8):e0134764. PubMed ID: 26241473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both.
    Mo L; Liaw L; Evan AP; Sommer AJ; Lieske JC; Wu XR
    Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1935-43. PubMed ID: 17898038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Tamm-Horsfall protein in stone-forming rat models.
    Miyake O; Yoshioka T; Yoshimura K; Honda M; Yamaguchi S; Koide T; Okuyama A
    Br J Urol; 1998 Jan; 81(1):14-9. PubMed ID: 9467470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal tubular damage/dysfunction: key to the formation of kidney stones.
    Khan SR
    Urol Res; 2006 Apr; 34(2):86-91. PubMed ID: 16404622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular mechanism of renal stone formation].
    Hamamoto S; Taguchi K; Fujii Y
    Clin Calcium; 2011 Oct; 21(10):1481-7. PubMed ID: 21960233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New pathophysiologic aspects of nephrolithiasis].
    Hess B
    Schweiz Med Wochenschr; 1989 Jul; 119(26):929-34. PubMed ID: 2678432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects.
    Glauser A; Hochreiter W; Jaeger P; Hess B
    Nephrol Dial Transplant; 2000 Oct; 15(10):1580-7. PubMed ID: 11007825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former.
    Hess B; Jordi S; Zipperle L; Ettinger E; Giovanoli R
    Nephrol Dial Transplant; 2000 Mar; 15(3):366-74. PubMed ID: 10692522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors.
    Huang HS; Chen J; Chen CF; Ma MC
    Kidney Int; 2006 Aug; 70(4):699-710. PubMed ID: 16807540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO; Schmiedl A; Wipplinger J
    Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis.
    Porile JL; Asplin JR; Parks JH; Nakagawa Y; Coe FL
    J Am Soc Nephrol; 1996 Apr; 7(4):602-7. PubMed ID: 8724894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Tamm-Horsfall protein in a rat nephrolithiasis model.
    Gokhale JA; Glenton PA; Khan SR
    J Urol; 2001 Oct; 166(4):1492-7. PubMed ID: 11547119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
    Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L
    J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary stone formation: Dent's disease moves understanding forward.
    Sayer JA; Simmons NL
    Exp Nephrol; 2002; 10(3):176-81. PubMed ID: 12053119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.